1-20 of 26
Avyakta Kallam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma

Available to Purchase
Clinical Trials & Observations
Juan Pablo Alderuccio, Diva Baggio, Sunwoo Han, Paola Ghione, Imran A Nizamuddin, Jahanzaib Khwaja, Aditi Saha, Ning Dong, Yucai Wang, Hua-Jay J. Cherng, Seda S. Tolu, Nina D. Wagner-Johnston, Thomas A. Ollila, Natalie S. Grover, Jean L Koff, Amrita Desai, Praveen Ramakrishnan Geethakumari, Tamara K Moyo, Jose Sandoval-Sus, Narendranath Epperla, Danielle S. Wallace, Manali Kamdar, Rita Tavarozzi, Alexey V Danilov, Han W. Tun, Javier Munoz, Mayur S. Narkhede, Joanna M Rhodes, Anca Prica, Andrea Kuhnl, Adrian Matthew Maraj, Jessica Okosun, Jeffery Smith, Wendy Osborne, Victoria Calvert, Dima El-Sharkawi, Ammar Hilali, Graham P. Collins, Kim Linton, Nagah Elmusharaf, Anna Santarsieri, Farheen Karim, Firas Baidoun Firas, Sarah Monick, Iris Margalit Trutzer, Jones Can, Amy A Ayers, Jacopo Calabrese De Feo, John Sharp, Nilanjan Ghosh, Rachel Treitman, Avyakta Kallam, Izel Okcu, Chathuri Abeyakoon, William Hann, Aisling Barrett, Vismay Deshani, Brad S Kahl, Julio C. Chavez, Adam J. Olszewski, Kate Cwynarski
Journal: Blood
Blood blood.2025031455.
https://doi.org/10.1182/blood.2025031455
Published: 2026
Includes: Supplemental data
Journal Articles

Interim analysis of the phase II study of glofitamab, lenaliomide and venetoclax (GLOVe) in untreated patients w/ high-risk mantle cell lymphoma. response and safety outcomes after the completion of stage 1 of 2 enrollment.

Free
Tycel Phillips, Lu Chen, Tiffanie Barnhizer, Alex Herrera, Geoffrey Shouse, Daniel Ermann, Reem Karmali, Adam Kittai, Manali Kamdar, Diane Smith, James Godfrey, Brian Sworder, Swetha Thiruvengadam, John Baird, Avyakta Kallam, Elizabeth Budde, Alexey Danilov
Journal: Blood
Blood (2025) 146 (Supplement 1): 883.
https://doi.org/10.1182/blood-2025-883
Published: 2025
Journal Articles

Phase II investigator-initiated trial of epcoritamab-lenalidomide in treatment naïve follicular lymphoma

Free
Swetha Thiruvengadam, Lu Chen, Vi Lam, Xiaofan Zhao, Avyakta Kallam, John Baird, Azra Borogovac, James Godfrey, Alex Herrera, Tycel Phillips, Abbey Fueger, Lara Rodriguez, Katie Romero, Neer Patel, Eunice Canche, Ashly Grafton, Dina Hassan, Diane Smith, Larry Kwak, Steven Rosen, Zheng Xia, Alexey Danilov
Journal: Blood
Blood (2025) 146 (Supplement 1): 5373.
https://doi.org/10.1182/blood-2025-5373
Published: 2025
Journal Articles

High rates of financial toxicity and time toxicity in patients receiving chimeric antigen receptor therapy and bispecific antibodies for lymphoma and multiple myeloma: A prospective mixed methods study.

Free
Swetha Thiruvengadam, Nishita Matangi, Murali Janakiram, Annie Xiao, Mark Ponce, Brian Lee, Stacy Pak, Benjamin Martini, Diamond Ward, Ryan Chiechi, Diane Smith, John Baird, Azra Borogovac, Elizabeth Budde, Alexey Danilov, Alex Herrera, Myo Htut, James Godfrey, Scott Goldsmith, Avyakta Kallam, Amrita Krishnan, Larry Kwak, Sarah Lee, Matthew Mei, Nitya Nathwani, Michael Rosenzweig, Firoozeh Sahebi, Tycel Phillips, Geoffrey Shouse, Tanya Siddiqi, Brian Sworder, Kimlin Ashing, Nikhil Thiruvengadam, Steven Rosen
Journal: Blood
Blood (2025) 146 (Supplement 1): 6364.
https://doi.org/10.1182/blood-2025-6364
Published: 2025
Journal Articles

BMS-986458, a first-in-class, bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6) in patients with Relapsed/Refractory (R/R) non-Hodgkin lymphoma (NHL): Updated results from the Phase 1 dose escalation study

Free
Franck Morschhauser, David Qualls, Jennifer Lue, Anastasios Stathis, Marcel Nijland, Avyakta Kallam, Jörg Bittenbring, Guillaume Cartron, Noémie Lang, Marjolein Van Der Poel, Loic Ysebaert, Vladan Vucinic, Alejandro Martin Garcia-Sancho, Antonio Rueda Dominguez, Noelia Purroy, Berengere De Moucheron, Xiaosong Li, Carla Guarinos, Joseph Burnett, Alicia Benítez Rondán, Michael Pourdehnad, Jessica Voetsch, Diego Sobradillo, Jean-Marie Michot
Journal: Blood
Blood (2025) 146 (Supplement 1): 480.
https://doi.org/10.1182/blood-2025-480
Published: 2025
Journal Articles

A Phase 2 Study of Loncastuximab Tesirine Plus Mosunetuzumab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Free
Swetha Kambhampati, Avyakta Kallam, Azra Borogovac, Lu Chen, Sandrine Puverel, Jennifer Johnson, Ivana Melgar, John H. Baird, Alexey Danilov, James Godfrey, Niloufer Khan, Matthew Mei, Tycel J. J. Phillips, Tanya Siddiqi, Geoffrey Shouse, Jasmine Zain, Larry W. Kwak, Steven T. Rosen, Stephen J. Forman, Joo Y. Song, Alex F. Herrera, Elizabeth Budde
Journal: Blood
Blood (2024) 144 (Supplement 1): 1742.1.
https://doi.org/10.1182/blood-2024-198727
Published: 2024
Journal Articles

Prognostication and Treatment-Related Outcomes in Secondary Central Nervous System Involvement of Large B-Cell Lymphoma (SCNSL): Evidence from a Large International Cohort

Free
Juan Pablo Alderuccio, Jahanzaib Khwaja, Sunwoo Han, Paola Ghione, Imran A. Nizamuddin, Aditi Saha, Ning Dong, Yucai Wang, Hua-Jay J Cherng, Seda S. Tolu, Nina Wagner-Johnston, Adam J. Olszewski, Natalie Grover, Jean L. Koff, Amrita Desai, Praveen Ramakrishnan Geethakumari, Tamara K Moyo, Jose Sandoval-Sus, Narendranath Epperla, Danielle S Wallace, Manali Kamdar, Alexey Danilov, Han W. Tun, Javier Munoz, Mayur S. Narkhede, Joanna M. Rhodes, Anca Prica, Andrea Kuhnl, Adrian Maraj, Jessica Okosun, Jeffery Smith, Wendy Osborne, Victoria Calvert, Dima el-Sharkawi, Ammar Hilali, Graham P. Collins, Kim Linton, Nagah Elmusharaf, Anna Santarsieri, Farheen Karim, Thomas Ollila, Sarah Monick, Iris Margalit Trutzer, Nilanjan Ghosh, Jones Can, Amy Ayers, Jacopo Calabrese De Feo, John Sharp, Rachel Treitman, Avyakta Kallam, Izel Okcu, Vismay Deshani, Firas Baidoun, Chathuri Abeyakoon, William Hann, Aisling Barrett, Brad Kahl, Julio C. Chavez, Kate Cwynarski
Journal: Blood
Blood (2024) 144 (Supplement 1): 571.
https://doi.org/10.1182/blood-2024-199781
Published: 2024
Journal Articles

The Predictive Value of Cell-of-Origin Subtype By Hans Algorithm in 718 Patients with Large B Cell Lymphoma Receiving Polatuzumab Vedotin

Free
Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan, Varun Iyengar, Jihao Zhou, Kevin Chung, Nayef Abdel-Razeq, Ajay Major, Jessica M Allen, John Sharp, Narendranath Epperla, Patrick Gould, Hua-Jay J Cherng, Samin Houshyar, Danielle S Wallace, Ryan C. Lynch, Avyakta Kallam, Matthew Mei, Reid W. Merryman, Michelle Fleyshman, Joanna M. Rhodes, Adam Kidwell, Timothy S Fenske, Erin Mulvey, Marcus P. Watkins, Muhamad Alhaj Moustafa, Talal Hilal, Grzegorz S. Nowakowski, Yucai Wang, Pallawi Torka, David A Russler-Germain
Journal: Blood
Blood (2024) 144 (Supplement 1): 652.
https://doi.org/10.1182/blood-2024-202153
Published: 2024
Journal Articles

Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) and Secondary Central Nervous System (sCNS) Involvement from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Free
Sairah Ahmed, Avyakta Kallam, Matthew Frigault, Bradley D. Hunter, Sagar S. Patel, David Bernasconi, Soyoung Kim, Tracy Krimmel, Fei Fei Liu, Debasmita Roy, Marcelo C. Pasquini, Jennifer L. Crombie
Journal: Blood
Blood (2024) 144 (Supplement 1): 472.
https://doi.org/10.1182/blood-2024-199702
Published: 2024
Journal Articles

Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma

Free
James K. Godfrey, Lei Gao, Geoffrey Shouse, Joo Y. Song, Stacy Pak, Brian Lee, Bihong T. Chen, Avyakta Kallam, John H. Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V. Danilov, Alex F. Herrera, Larry W. Kwak, Lihua E. Budde
Journal: Blood
Blood (2024) 144 (4): 457–461.
https://doi.org/10.1182/blood.2024024168
Published: 2024
Includes: Supplemental data
Journal Articles

A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Relapsed/Refractory (R/R) B-Cell Lymphoma (NHL) or Acute Myeloid Leukemia (AML)

Free
Matthew S Davids, Yesid Alvarado Valero, Catherine Diefenbach, Daniel N. Egan, Shira N. Dinner, Monzr M. Al Malki, Kebede Begna, Avyakta Kallam, Sameem Abedin, Rachel Cook, Nathalie Javidi-Sharifi, Edward Dominguez, Lu Miao, Richard G Ghalie, Alexey Danilov
Journal: Blood
Blood (2023) 142 (Supplement 1): 4286.
https://doi.org/10.1182/blood-2023-179577
Published: 2023
Journal Articles

Waveline-001: Updated Results from a Phase 1 Dose Escalation and Cohort Expansion Study of Zilovertamab Vedotin (MK-2140) in Non-Hodgkin Lymphoma

Free
Stephen E. Spurgeon, Matthew Mei, Paul M. Barr, Jacqueline C. Barrientos, Sven de Vos, Richard R. Furman, Krish Patel, Philip A. Thompson, Michael Y. Choi, Avyakta Kallam, Sirou Wang, Uzor C. Ogbu, Akash Nahar, Michael L. Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 6640–6641.
https://doi.org/10.1182/blood-2022-163509
Published: 2022
Journal Articles

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Free
Clinical Trials & Observations
Victor Manuel Orellana-Noia, Daniel R. Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M. Barlow, Mary-Kate Malecek, Marcus Watkins, Brad S. Kahl, Michael A. Spinner, Ranjana Advani, Timothy J. Voorhees, Anson Snow, Natalie Sophia Grover, Amy Ayers, Jason Romancik, Yuxin Liu, Scott F. Huntington, Julio C. Chavez, Hayder Saeed, Aleksandr Lazaryan, Vikram Raghunathan, Stephen E. Spurgeon, Thomas A. Ollila, Christopher Del Prete, Adam Olszewski, Emily C. Ayers, Daniel J. Landsburg, Benjamin Echalier, Jun Lee, Manali Kamdar, Paolo F. Caimi, Timothy Fu, Jieqi Liu, Kevin A. David, Hanan Alharthy, Jennie Law, Reem Karmali, Harsh Shah, Deborah M. Stephens, Ajay Major, Alexandra E. Rojek, Sonali M. Smith, Amulya Yellala, Avyakta Kallam, Shazi Nakhoda, Nadia Khan, Mohammad Ahsan Sohail, Brian T. Hill, Odeth Barrett-Campbell, Frederick Lansigan, Jeffrey Switchenko, Jonathon Cohen, Craig A. Portell
Journal: Blood
Blood (2022) 139 (3): 413–423.
https://doi.org/10.1182/blood.2021012888
Published: 2022
Includes: Supplemental data
Journal Articles

A Phase 1 Dose-Escalation Study of the Oral CDK Inhibitor Voruciclib in Patients with Relapsed/Refractory B-Cell Malignancies or Acute Myeloid Leukemia (AML): Preliminary Results of the Completed Dose Escalation Stage in AML

Free
Marina Konopleva, Danielle M. Brander, Krish Patel, Catherine S. Diefenbach, Yesid Alvarado, Olga Frankfurt, Monzr M. Al Malki, Alexey V. Danilov, Sameem Abedin, Kebede H. Begna, Avyakta Kallam, Richard G. Ghalie, Matthew S. Davids
Journal: Blood
Blood (2021) 138 (Supplement 1): 3423.
https://doi.org/10.1182/blood-2021-146079
Published: 2021
Journal Articles

Phase 1 Dose Escalation and Cohort Expansion Study of the Anti-ROR1 Antibody-Drug Conjugate Zilovertamab Vedotin (MK-2140) for the Treatment of Non-Hodgkin Lymphoma

Free
Michael Wang, Matthew Mei, Paul M. Barr, Jacqueline Barrientos, Sven de Vos, Richard Furman, Krish Patel, Philip A. Thompson, Michael Choi, Avyakta Kallam, Ying Zhu, Samhita Chakraborty, Patricia Marinello, Stephen E. Spurgeon
Journal: Blood
Blood (2021) 138 (Supplement 1): 528.
https://doi.org/10.1182/blood-2021-148607
Published: 2021
Journal Articles

Thrombosis Prophylaxis with Apixaban in Patients Treated with Asparaginase

Free
Krishna Gundabolu, Vijaya R. Bhatt, Lynette M. Smith, Valerie K Shostrom, Lori J. Maness, Zaid S. Al-Kadhimi, Julie M. Vose, R. Gregory Bociek, Matthew A. Lunning, Avyakta Kallam, Christopher D'Angelo, Muhamed Baljevic, Apar K Ganti
Journal: Blood
Blood (2021) 138 (Supplement 1): 1069.
https://doi.org/10.1182/blood-2021-148945
Published: 2021
Journal Articles

BET Inhibition As a Targeted Epigenetic Approach to Reverse T Cell Dysfunction in Chronic Lymphocytic Leukemia

Free
Audrey L Smith, Alexandria P Eiken, Sydney A Skupa, Dalia Y Moore, Avyakta Kallam, Christopher D'Angelo, Gregory R Bociek, Matthew A. Lunning, Julie M. Vose, Ben Powell, Gideon Bollag, Dalia ElGamal
Journal: Blood
Blood (2021) 138 (Supplement 1): 3715.
https://doi.org/10.1182/blood-2021-153921
Published: 2021
Journal Articles

CNS Prophylaxis during Front-Line Therapy in Aggressive Non-Hodgkin Lymphomas: Real-World Outcomes and Practice Patterns from 19 US Academic Institutions

Free
Victor M. Orellana-Noia, MD, Daniel R Reed, MD, Jeremy M Sen, PharmD, BCOP, Christian Barlow, MD, Mary-Kate Malecek, MD, Brad S. Kahl, MD, Michael A Spinner, MD, Ranjana Advani, MD, Timothy J Voorhees, MD, Anson Snow, MD, Natalie S Grover, MD, Amy Ayers, MPH, Jason T. Romancik, MD, Yuxin Liu, MD, Scott F. Huntington, MD MPH, Julio C. Chavez, MD, Hayder Saeed, MD, Aleksandr Lazaryan, MDPhDMPH, Vikram Raghunathan, MD, Stephen E. Spurgeon, MD, Thomas A Ollila, MD, Christopher Del Prete, MD, Adam J Olszewski, MD, Emily C. Ayers, MD, Daniel J. Landsburg, MD, Benjamin Echalier, Jun Lee, Manali Kamdar, MD, Paolo F Caimi, MD, Timothy Fu, MD, Jieqi Liu, MD, Kevin A. David, MD, Hanan Alharthy, MD, Jennie Y. Law, MD, Reem Karmali, MDMSc, Harsh Shah, DO, Deborah M. Stephens, DO, Ajay Major, MDMBA, Alexandra E Rojek, MD, Sonali M. Smith, MD, Amulya Yellala, MBBS, Avyakta Kallam, MD, Shazia Nakhoda, MD, Nadia Khan, MD, Jonathon B. Cohen, MDMS, Craig A. Portell, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-134798
Published: 2020
Journal Articles

VLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma

Free
Michael Wang, MD, Jacqueline C. Barrientos, MD, Richard R. Furman, MD, Matthew Mei, MD, Paul M. Barr, MD, Michael Y. Choi, MD, Sven de Vos, MD PhD, Avyakta Kallam, MD, Krish Patel, MD, Simon Rule, MD PhD, Kate Flanders, BS, Katti A. Jessen, PhD, Peter C. Riebling, Patricia Graham, BHSA, Lydia King, PhD, Elizabeth M. Schmidt, BSN, Brian J. Lannutti, PhD, David M. Johnson, BS, Langdon L. Miller, MD, Stephen E. Spurgeon, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-136373
Published: 2020
Journal Articles

Thirty-Five Year Follow-up Analysis of Follicular Lymphoma Patients Treated through the Nebraska Lymphoma Study Group: Prognostic Factor Analysis and Outcomes

Free
Amulya Yellala, MBBS, Elizabeth R. Lyden, MS, Heather Nutsch, Avyakta Kallam, MD, Kai Fu, MD PhD, Timothy C. Greiner, MS, MD, Philip Bierman, MD, Matthew A. Lunning, DO, FACP, R. Gregory Bociek, MD, James O. Armitage, MD, Julie M. Vose, MD MBA
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-142743
Published: 2020